Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Dec 27;29(8):taac111.
doi: 10.1093/jtm/taac111.

Is standby therapy for Covid-19 a practical option for travellers?

Lin H Chen  1 , Bradley A Connor  2
Affiliations

Is standby therapy for Covid-19 a practical option for travellers?

Lin H Chen et al. J Travel Med. .

Abstract

International travel has resumed while the risk of SARS-CoV-2 persists, leading to consideration of medications that can treat or prevent Covid-19 when travellers become ill abroad. Nirmatrelvir-ritonavir, molnupiravir and tixagevimab-cilgavimab are available under Emergency Use Authorization or conditional approval. We discuss the potential application of these medications to protect travellers.

Keywords: Nirmatrelvir-ritonavir; antiviral; authorization; immunocompromised; molnupiravir; monoclonal; tixagevimab-cilgavimab.

PubMed Disclaimer

Comment in

References

    1. Flaherty GT, Hamer DH, Chen LH. Travel in the time of COVID: a review of international travel health in a global pandemic. Curr Infect Dis Rep 2022; 24:129–45. Epub ahead of print. PMID: 35965881; PMCID: PMC9361911. - PMC - PubMed
    1. Krause PR, Fleming TR, Longini IMet al. . SARS-CoV-2 variants and vaccines. N Engl J Med 2021; 385:179–86. - PMC - PubMed
    1. Hammond J, Leister-Tebbe H, Gardner Aet al. . Oral nirmatrelvir for high-risk, nonhospitalized adults with Covid-19. N Engl J Med 2022; 386:1397–408. - PMC - PubMed
    1. Jayk Bernal A, Gomes da Silva MM, Musungaie DBet al. . Molnupiravir for oral treatment of Covid-19 in nonhospitalized patients. N Engl J Med 2022; 386:509–20. - PMC - PubMed
    1. Levin MJ, Ustianowski A, De Wit Set al. . Intramuscular AZD7442 (Tixagevimab-Cilgavimab) for prevention of Covid-19. N Engl J Med 2022; 386:2188–2200. - PMC - PubMed

Substances